Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Hangzhou Tigermed Consulting Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Hangzhou Tigermed Consulting Co Ltd tiene un total de activos de $28,671, una ganancia neta profit de $405

Question 2

¿Cuáles son los ratios financieros clave para HNGZY?

Accepted Answer

El ratio corriente de Hangzhou Tigermed Consulting Co Ltd es 3.58, el margen neto es 6.13, las ventas por acción son $7.65.

Question 3

¿Cómo se desglosan los ingresos de Hangzhou Tigermed Consulting Co Ltd por segmento o geografía?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd largest revenue segment is Clinical Trial Technical Services, at a revenue of 4,168,128,309 in the most earnings release.For geography, China is the primary market for Hangzhou Tigermed Consulting Co Ltd, at a revenue of 4,234,516,020.

Question 4

¿Es rentable Hangzhou Tigermed Consulting Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Hangzhou Tigermed Consulting Co Ltd tiene una ganancia neta profit de $405

Question 5

¿Tiene Hangzhou Tigermed Consulting Co Ltd alguna deuda?

Accepted Answer

yes, Hangzhou Tigermed Consulting Co Ltd tiene una deuda de 8,000

Question 6

¿Cuántas acciones en circulación tiene Hangzhou Tigermed Consulting Co Ltd?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd tiene un total de acciones en circulación de 861.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6,561	6,603	7,384	7,085	5,213	3,192
Revenue Growth (YoY)	-4%	-11%	4%	36%	63%	14%
Cost of Revenue	4,855	4,358	4,538	4,277	2,942	1,678
Gross Profit	1,706	2,244	2,845	2,808	2,270	1,514
Selling, General & Admin	965	860	782	722	652	435
Research & Development	257	229	254	229	211	151
Operating Expenses	1,174	1,154	1,132	1,028	841	557
Other Non Operating Income (Expenses)	-8	0	1	2	-12	-4
Pretax Income	800	664	2,488	2,585	3,684	2,218
Income Tax Expense	163	216	338	313	292	189
Net Income	612	405	2,024	2,006	2,874	1,749
Net Income Growth	-36%	-80%	1%	-30%	64%	108%
Shares Outstanding (Diluted)	868.8	863.04	865.32	864.89	870.95	799
Shares Change (YoY)	0%	0%	0%	-1%	9%	7%
EPS (Diluted)	0.7	0.46	2.34	2.32	3.3	2.19
EPS Growth	-36%	-80%	1%	-30%	51%	94%
Free Cash Flow	1,005	740	836	908	1,055	842
Free Cash Flow Per Share	1.15	0.85	0.96	1.04	1.21	1.05
Gross Margin	26%	33.98%	38.52%	39.63%	43.54%	47.43%
Operating Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Profit Margin	9.32%	6.13%	27.41%	28.31%	55.13%	54.79%
Free Cash Flow Margin	15.31%	11.2%	11.32%	12.81%	20.23%	26.37%
EBITDA	--	1,241	1,838	1,889	1,500	1,013
EBITDA Margin	--	18.79%	24.89%	26.66%	28.77%	31.73%
D&A For EBITDA	--	152	126	110	71	57
EBIT	531	1,089	1,712	1,779	1,429	956
EBIT Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Effective Tax Rate	20.37%	32.53%	13.58%	12.1%	7.92%	8.52%

Hangzhou Tigermed Consulting Co Ltd (HNGZY) Price

HNGZY Stock Price Chart

HNGZY Income

Follow-Up Questions